Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab Plus Radiotherapy in Advanced NSCLC
NCT03044626Phase 2Completed
- Sponsor
- AIO-Studien
- Start
- Feb 2017
- Primary completion
- Dec 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in non-squamous non-small cell lung cancer, sponsored by AIO-Studien. Started Feb 2017; status: completed.
02
Drugs
03
Conditions
non-squamous non-small cell lung cancer
Beyond the preview
Go deeper on NCT03044626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03044626.